Back to Search
Start Over
Dapsone, More than an Effective Neuro and Cytoprotective Drug
- Source :
- Current Neuropharmacology. 20:194-210
- Publication Year :
- 2022
- Publisher :
- Bentham Science Publishers Ltd., 2022.
-
Abstract
- Background:Dapsone (4,4'-diamino-diphenyl sulfone) is a synthetic derivative of sulfones, with the antimicrobial activity described since 1937. It is also a drug traditionally used in dermatological therapies due to its anti-inflammatory effect. In recent years its antioxidant, antiexcitotoxic, and antiapoptotic effects have been described in different ischemic damage models, traumatic damage, and models of neurodegenerative diseases, such as Parkinson's (PD) and Alzheimer's diseases (AD). Finally, dapsone has proven to be a safe and effective drug as a protector against heart, renal and pulmonary cells damage; that is why it is now employed in clinical trials with patients as a neuroprotective therapy by regulating the main mechanisms of damage that lead to cell death.Objective:To provide a descriptive review of the evidence demonstrating the safety and therapeutic benefit of dapsone treatment, evaluated in animal studies and various human clinical trials.Methods:We conducted a review of PubMed databases looking for scientific research in animals and humans, oriented to demonstrate the effect of dapsone on regulating and reducing the main mechanisms of damage that lead to cell death.Conclusion:The evidence presented in this review shows that dapsone is a safe and effective neuro and cytoprotective treatment that should be considered for translational therapy.
- Subjects :
- Drug
media_common.quotation_subject
Apoptosis
Dapsone
Bioinformatics
Neuroprotection
Antioxidants
Animals
Humans
Medicine
Pharmacology (medical)
media_common
Pharmacology
business.industry
General Medicine
Cytoprotection
Clinical trial
Psychiatry and Mental health
Pharmaceutical Preparations
Neurology
Neurology (clinical)
Animal studies
business
medicine.drug
Subjects
Details
- ISSN :
- 1570159X
- Volume :
- 20
- Database :
- OpenAIRE
- Journal :
- Current Neuropharmacology
- Accession number :
- edsair.doi.dedup.....da5a32b1e10471fa83bcd4b96547b354
- Full Text :
- https://doi.org/10.2174/1570159x19666210617143108